BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20353368)

  • 21. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.
    ; Yee HS; Currie SL; Darling JM; Wright TL
    Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplant in hepatitis B and C positive patients--a ten years experience.
    Rathod JR; Sirsat RA; Shah BV
    J Assoc Physicians India; 2002 Jun; 50():766-70. PubMed ID: 12240839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kidney transplantation in patients positive for hepatitis C virus].
    Campistol JM; Esforzado N; Morales JM; Barrera JM
    Nefrologia; 2002; 22 Suppl 5():62-6. PubMed ID: 12107920
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of HCV in patients with renal failure.
    Kalia H; Lopez PM; Martin P
    Arch Med Res; 2007 Aug; 38(6):628-33. PubMed ID: 17613354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James.
    Dieterich D
    AIDS Treat News; 1998 May; (No 295):1-5. PubMed ID: 11365406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic hepatitis C in patients with renal disease.
    Gane E
    Med J Malaysia; 2005 Jul; 60 Suppl B():72-6. PubMed ID: 16108179
    [No Abstract]   [Full Text] [Related]  

  • 32. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C.
    Latin American Association for the Study of the Liver
    Ann Hepatol; 2010; 9 Suppl():8-26. PubMed ID: 20713990
    [No Abstract]   [Full Text] [Related]  

  • 33. [Progress in blood purification medicine in 2011].
    Takeda T
    Nihon Jinzo Gakkai Shi; 2012; 54(1):11-6. PubMed ID: 22413573
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferon for hepatitis C: where it has been and where it is going.
    Koretz RL
    Immunotherapy; 2013 Jul; 5(7):673-5. PubMed ID: 23829615
    [No Abstract]   [Full Text] [Related]  

  • 35. Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology.
    Algaba F; Delahunt B; Berney DM; Camparo P; Compérat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Martignoni G; Moch H; Montironi R; Varma M; Egevad L
    J Clin Pathol; 2012 Feb; 65(2):106-13. PubMed ID: 21965832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and treatment of the HCV-infected kidney transplant patient.
    Wong T; Bloom RD
    Semin Dial; 2019 Mar; 32(2):169-178. PubMed ID: 30536995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
    European Association for the Study of the Liver
    J Hepatol; 2011 Aug; 55(2):245-64. PubMed ID: 21371579
    [No Abstract]   [Full Text] [Related]  

  • 38. [Standards of hepatitis C treatment. Recommendations of Polish Group of Experts].
    Halota W; Flisiak R; Boroń-Kaczmarska A; Juszczyk J; Cianciara J; Pawłowska M; Simon K; Małkowski P;
    Przegl Epidemiol; 2012; 66(1):83-8. PubMed ID: 22708304
    [No Abstract]   [Full Text] [Related]  

  • 39. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
    Rao HY; Duan ZP; Wang GQ; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs).
    La Manna G
    J Nephrol; 2018 Apr; 31(2):185-187. PubMed ID: 29411309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.